Cargando…

Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies

BACKGROUND: Bradykinin-mediated angioedema (Bk-AE) can be life-threatening and requires specific targeted therapies. Knowledge of its epidemiology may help optimize its management. METHODS: We systematically searched the medical literature to identify abstracts of interest indexed between 1948 and M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aygören-Pürsün, Emel, Magerl, Markus, Maetzel, Andreas, Maurer, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935942/ https://www.ncbi.nlm.nih.gov/pubmed/29728119 http://dx.doi.org/10.1186/s13023-018-0815-5

Ejemplares similares

Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell–Mediated Angioedema
por: Maurer, Marcus, et al.
Publicado: (2021)

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe
por: Aygören-Pürsün, Emel, et al.
Publicado: (2014)

On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
por: Aygören-Pürsün, Emel, et al.
Publicado: (2010)

Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
por: Maurer, M., et al.
Publicado: (2018)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

Pathophysiology of bradykinin and histamine mediated angioedema
por: Lima, Hermenio, et al.
Publicado: (2023)

Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema()
por: Can, Pelin Kuteyla, et al.
Publicado: (2021)

Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema
por: Aygören-Pürsün, Emel, et al.
Publicado: (2016)

Individual approach to long-term therapy in patients with hereditary angioedema (HAE-C1-INH): A case series
por: Andarawewa, S., et al.
Publicado: (2022)

In Vitro Modeling of Bradykinin-Mediated Angioedema States
por: Marceau, François, et al.
Publicado: (2020)

549 Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (Hae) Undergoing Home Treatment—A Clinical Surveillance Program
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2012)

The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology
por: Bygum, Anette, et al.
Publicado: (2012)

Bradykinin and the Pathogenesis of Hereditary Angioedema
por: Kaplan, Allen P
Publicado: (2011)

Bradykinin-induced angioedema in the emergency department
por: Hébert, Jacques, et al.
Publicado: (2022)

Bradykinin Metabolism and Drug-Induced Angioedema
por: Smolinska, Sylwia, et al.
Publicado: (2023)

Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
por: Marcelino-Rodriguez, Itahisa, et al.
Publicado: (2019)

Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?
por: Debreczeni, Márta L., et al.
Publicado: (2021)

Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema
por: Defendi, Federica, et al.
Publicado: (2013)

Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey
por: Mendivil, Joan, et al.
Publicado: (2021)

Risk of angioedema following invasive or surgical procedures in HAE type I and II – the natural history
por: Aygören-Pürsün, E, et al.
Publicado: (2013)

Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
por: Andarawewa, Shimalee, et al.
Publicado: (2021)

Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies
por: Gower, Richard G, et al.
Publicado: (2011)

Corrigendum: Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
por: Marcelino-Rodriguez, Itahisa, et al.
Publicado: (2020)

Commentary: Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
por: Colobran, Roger
Publicado: (2020)

Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges
por: Mormile, Ilaria, et al.
Publicado: (2023)

Correction: Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema
Publicado: (2014)

Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2014)

Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat
por: Cohn, Danny M., et al.
Publicado: (2023)

Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
por: Hintze, Stefan, et al.
Publicado: (2023)

A Comprehensive Review of Bradykinin-Induced Angioedema Versus Histamine-Induced Angioedema in the Emergency Department
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012)

Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
por: Riedl, Marc
Publicado: (2010)

Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe
por: Zanichelli, Andrea, et al.
Publicado: (2013)

A challenging case of bradykinin-mediated angioedema with airway obstruction: management and therapeutic strategies
por: Nunes, Lisete Rolo, et al.
Publicado: (2023)

A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema
por: Aygören‐Pürsün, Emel, et al.
Publicado: (2019)

Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study
por: Schulkes, Karlijn J G, et al.
Publicado: (2015)

Case report: Recurrent angioedema: Diagnosing the rare and the frequent
por: Buttgereit, Thomas, et al.
Publicado: (2022)

Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study
por: Farkas, Henriette, et al.
Publicado: (2021)

The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Dyga, Wojciech, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08rlo0sdc6ajvqdvgl64v282vb